It was confirmed that knockdown of LINC01004 or SPI1 could specifically inhibit SIGLEC9, induce TAM reprogramming and eventually convert to the M1 subtype, thus alleviating immunosuppression and radioresistance in ESCC [86]. Here, SIGLEC9 is linked to esophageal squamous cell carcinoma.